Chimeric anti-GPC3 sFv-CD3ε receptor-modified T cells with IL7 co-expression for the treatment of solid tumors

by Dong, Y., Jiang, H., Li, Z., Liu, Y., Luo, H., Shi, B., Sun, R., Sun, Y., Wang, Y.
Published 2022

COVID-19 and cancer: start the resolution!

by Barksdale, C., Kipper, F.C, Panigrahy, D., Serhan, C.N, Subbian, S., Tripathy, S.
Published 2022

Tisagenlecleucel outcomes in relapsed/refractory extramedullary ALL: A Pediatric Real World CAR Consortium Report

by Baggott, C., Brown, P.A, Chinnabhandar, V., Curran, K.J, Egeler, E., Fabrizio, V.A, Hermiston, M., Karras, N.A, Keating, A.K, Krupski, C., Kunicki, M., Laetsch, T.W, Lane, A., Mackall, C.L, Margossian, S.P, Mavroukakis, S., Moskop, A., Myers, G.D, Pacenta, H., Phillips, C.L, Prabhu, S., Qayed, M., Rabik, C.A, Rossoff, J., Satwani, P., Schultz, L.M, Stefanski, H.E, Talano, J.-A, Verneris, M.R, Wilcox, R., Yasemin Goksenin, A.
Published 2022

Single-center experience using anakinra for steroid-refractory immune effector cell-Associated neurotoxicity syndrome (ICANS)

by Chen, Y.-B, Cook, D., Defilipp, Z., Dey, B., El-Jawahri, A.R, Frigault, M.J, Gallagher, K., Horick, N., Leick, M.B, Lindell, K., Maus, M.V, McAfee, S.L, O'Donnell, P., Spitzer, T., Trailor, M., Wehrli, M.
Published 2022

Phase I clinical trial evaluating the safety and efficacy of ADP-A2M10 SPEAR T cells in patients with MAGE-A10+ advanced non-small cell lung cancer

by Bachier, C., Bai, J., Batrakou, D., Blumenschein, G.R, Broad, R., Devarakonda, S., Doger de Spéville, B., Edelman, M.J, Fayngerts, S., Fracasso, P.M, Frigault, M.J, Gainor, J., Gerry, A., Govindan, R., Heymach, J.V, Holdich, T., Hyland, N., Johnson, M., Lam, V.K, Marks, D., Moreno, V., Navenot, J.-M, Norry, E., Olszanski, A.J, Pentony, M.M, Sanderson, J.P, Wolchinsky, Z.
Published 2022